null

Alemtuzumab (Anti-CD52) Biosimilar Antibody

SKU:
HDBS0030
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CD52
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-CD52 alemtuzumab biosimilar mAb HDBS0030
  • Anti-CD52 alemtuzumab biosimilar mAb HDBS0030
$448
Frequently bought together:

Description

system_update_altDatasheet

Alemtuzumab (Anti-CD52) Biosimilar Antibody (HDBS0030)

Based on the information provided in the URL, I will provide a product description based on the specific product mentioned.The Anti-CD52 (Alemtuzumab) Biosimilar Monoclonal Antibody (HDBS0030) is a cutting-edge research tool designed for studying the CD52 cell surface molecule. CD52 is a protein found on the surface of certain immune cells, and plays a crucial role in immune regulation. This antibody, developed as a biosimilar to Alemtuzumab, a well-known therapeutic antibody targeting CD52, is highly specific and reactive with human samples.Validated for use in various research applications including Western blotting, this monoclonal antibody enables the detection and analysis of CD52 in different cell types. Its high affinity binding to CD52 makes it an excellent tool for studies in immunology, cancer research, and other areas where CD52 is implicated.

CD52 is known for its role in immune cell function and its potential as a target for therapeutic intervention in diseases such as cancer, autoimmune disorders, and inflammatory conditions. By using this monoclonal antibody, researchers can deepen their understanding of CD52's function and explore its potential as a target for novel treatments in these disease contexts.Overall, the Anti-CD52 (Alemtuzumab) Biosimilar Monoclonal Antibody (HDBS0030) is a valuable tool for researchers looking to delve into the complexities of immune regulation and explore new avenues for therapeutic development in